Get started
Author

Noriko Oza

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
2023 · Josep M Llovet, Masatoshi Kudo, et al. · The Lancet Oncology · 509
PDF
A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff
2009 · Noriko Oza, Yuichiro Eguchi, et al. · Journal of Gastroenterology · 94
Clinical practice of acute pancreatitis in Japan: An analysis of nationwide epidemiological survey in 2016
2020 · Atsushi Masamune, Kazuhiro Kikuta, et al. · Pancreatology · 65
Nationwide epidemiological survey of chronic pancreatitis in Japan: introduction and validation of the new Japanese diagnostic criteria 2019
2020 · Atsushi Masamune, Kazuhiro Kikuta, et al. · Journal of Gastroenterology · 64
Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitis
2021 · Jun Itakura, Masayuki Kurosaki, et al. · Journal of Gastroenterology · 61
Current activities and future directions of comprehensive hepatitis control measures in Japan: The supportive role of the Hepatitis Information Center in building a solid foundation
2017 · Noriko Oza, Hiroshi Isoda, et al. · Hepatology Research · 61
PDF
Prediction of Nonalcoholic Fatty Liver Disease Using Noninvasive and Non-Imaging Procedures in Japanese Health Checkup Examinees
2021 · Kenichiro Murayama, Michiaki Okada, et al. · Diagnostics · 45
PDF
Waist circumference correlates with hepatic fat accumulation in male Japanese patients with non‐alcoholic fatty liver disease, but not in females
2008 · Eriko Ishibashi, Yuichiro Eguchi, et al. · Journal of Gastroenterology and Hepatology · 44
PDF
Eradication of hepatitis C virus by interferon improves whole‐body insulin resistance and hyperinsulinaemia in patients with chronic hepatitis C
2009 · Yasunori Kawaguchi, Toshihiko Mizuta, et al. · Liver International · 42
Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C
2011 · Hirokazu Takahashi, Toshihiko Mizuta, et al. · Journal of Gastroenterology · 39
Epidemiological survey of hemoglobin A1c and liver fibrosis in a general population with non‐alcoholic fatty liver disease
2018 · Kenichi Tanaka, Hirokazu Takahashi, et al. · Hepatology Research · 38
Clinical characteristics of immunoglobulin IgG4-related sclerosing cholangitis: Comparison of cases with and without autoimmune pancreatitis in a large cohort
2021 · Itaru Naitoh, Terumi Kamisawa, et al. · Digestive and Liver Disease · 35
Hepatitis C virus infection enhances insulin resistance induced by visceral fat accumulation
2009 · Yuichiro Eguchi, Toshihiko Mizuta, et al. · Liver International · 32
Whole-Body Insulin Sensitivity Index Is a Highly Specific Predictive Marker for Virological Response to Peginterferon Plus Ribavirin Therapy in Chronic Hepatitis C Patients with Genotype 1b and High Viral Load
2009 · Toshihiko Mizuta, Yasunori Kawaguchi, et al. · Digestive Diseases and Sciences · 24
Gemcitabine plus nab-paclitaxel in older patients with metastatic pancreatic cancer: A post-hoc analysis of the real-world data of a multicenter study (the NAPOLEON study)
2021 · Futa Koga, Yasunori Kawaguchi, et al. · Journal of Geriatric Oncology · 21
Metabolic factors are associated with serum alanine aminotransferase levels in patients with chronic hepatitis C
2010 · Yumi Kobayashi, Yasunori Kawaguchi, et al. · Journal of Gastroenterology · 16
Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2
2023 · Masatoshi Murakami, Nao Fujimori, et al. · Journal of Gastroenterology · 13
Efficacy of ezetimibe for reducing serum low‐density lipoprotein cholesterol levels resistant to lifestyle intervention in patients with non‐alcoholic fatty liver disease
2013 · Noriko Oza, Hirokazu Takahashi, et al. · Hepatology Research · 13
Nationwide survey on activities of regional core centers for the management of liver disease in Japan: Cumulative analyses by the Hepatitis Information Center 2009–2017
2019 · Hiroko Setoyama, Masaaki Korenaga, et al. · Hepatology Research · 12
PDF
Pemafibrate for treating MASLD complicated by hypertriglyceridaemia: a multicentre, open-label, randomised controlled trial study protocol
2024 · Michihiro Iwaki, Takashi Kobayashi, et al. · BMJ Open · 10
PDF
Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitis
2009 · Hiroaki Kusunoki, Masayasu Kusaka, et al. · Journal of Gastroenterology · 9
Impairment of health-related quality of life in patients with chronic hepatitis C is associated with insulin resistance
2013 · Takuya Kuwashiro, Toshihiko Mizuta, et al. · Journal of Gastroenterology · 8
Rising burden of metabolic dysfunction-associated steatotic liver disease in adolescents aged 15–19 years and projections to 2035
2025 · Youxin Wang, Noriko Oza, et al. · Diabetes Research and Clinical Practice · 4
Nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable or recurrent pancreatic cancer: a multicenter observational study (NAPOLEON-2)
2025 · T. Shirakawa, M. Shimokawa, et al. · ESMO Gastrointestinal Oncology · 4
PDF
Development of performance indicators for hepatitis countermeasures as a tool for the assessment and promotion of liver cancer prevention in Japan
2023 · Tetsuro Shimakami, Hiroko Setoyama, et al. · Journal of Gastroenterology · 4
PDF
Works count: 51
Citation count: 1,293
H-index: 16
I10-index: 20
Year
Topic
Type